Transdermal Patches Market worth $24.84 billion by 2030, growing at a CAGR of 16.40% - Exclusive Report by 360iResearch

The "Transdermal Patches Market by Product (Matrix, Multi-layer Drug-in-Adhesive, Reservoir), Type (Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch), Technology, Application, Distribution Channel, End Users - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Transdermal Patches Market to grow from USD 8.57 billion in 2023 to USD 24.84 billion by 2030, at a CAGR of 16.40%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/transdermal-patches?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Transdermal patches offer a novel therapeutic approach to managing chronic conditions by delivering medication directly through the skin into the bloodstream. These patches are used for a range of purposes, including nicotine cessation, hormone replacement therapy, pain management, and the administration of anti-hypertensive, anti-inflammatory, and contraceptive medications. The growing aging population facing difficulty in oral medication administration may benefit from the ease of use of transdermal patches. The prevalence of chronic diseases and the rising preference for non-invasive drug delivery methods are raising the need for transdermal patches. However, high costs and limitations associated with transdermal patches can impede end-user adoption. Moreover, ongoing R&D to develop innovative drug delivery systems and enhance the effectiveness and range of available transdermal drug delivery systems are expected to encourage their use to treat chronic conditions globally.

The transdermal patches market is developing in the Americas owing to the advanced healthcare infrastructure, high healthcare expenditure, increasing prevalence of chronic diseases, and the presence of key market players actively involved in developing new transdermal technologies. Favorable regulatory policies and a strong focus on research and development activities contribute to the transdermal patch market's growth in the Americas. Europe is another crucial market for transdermal patches owing to the increasing geriatric population with chronic conditions requiring convenient medication delivery options such as transdermal patches. Governments and healthcare organizations across Europe have been advocating for cost-effective treatment methods consistent with an at-home healthcare trend, significantly driving the need for self-administered therapies such as transdermal patches. Health infrastructure and economic developments are improving the accessibility and adoption of transdermal patches by end-users in the Middle East and Africa region. The Asia-Pacific region is emerging as the fastest-growing market for transdermal patches due to increasing healthcare awareness and the growing need for chronic disease management. Improvements in healthcare infrastructure and rising income levels are forecasted to support the growth of the transdermal patches market in the APAC region.

Market Segmentation & Coverage:

This research report categorizes the Transdermal Patches Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Matrix, Multi-layer Drug-in-Adhesive, Reservoir, and Single-layer Drug-in-Adhesive. The Single-layer Drug-in-Adhesive commanded largest market share of 30.27% in 2023, followed by Matrix.

Based on Type, market is studied across Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, and Oxybutynin Transdermal Patch. The Buprenorphine Transdermal Patch commanded largest market share of 37.69% in 2023, followed by Fentanyl Transdermal Patch.

Based on Technology, market is studied across Chemical Enhancers, Electric Current, Mechanical Arrays, and Thermal Ablation. The Mechanical Arrays commanded largest market share of 41.73% in 2023, followed by Chemical Enhancers.

Based on Application, market is studied across Hormonal Therapy, Overactive Bladder, Pain Relief, and Smoking Reduction & Cessation Aid. The Pain Relief commanded largest market share of 40.60% in 2023, followed by Smoking Reduction & Cessation Aid.

Based on Distribution Channel, market is studied across Offline and Online. The Offline commanded largest market share of 81.23% in 2023, followed by Online.

Based on End Users, market is studied across Clinics, Home Care Settings, and Hospitals. The Hospitals commanded largest market share of 61.76% in 2023, followed by Home Care Settings.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.18% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/transdermal-patches?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Transdermal Patches Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Transdermal Patches Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdhexPharma SAS, ALVOGEN, Amneal Pharmaceuticals, Inc., Bayer AG, BioNxt Solutions Inc., Bliss GVS Pharma Ltd., Boehringer Ingelheim International GmbH, Corium, Inc., Corsair Pharma, Inc., DifGen Pharmaceuticals LLC, Endo International plc, Gedeon Richter Plc, GlaxoSmithKline Plc, Icure Pharmaceutical Inc., Johnson & Johnson Services, Inc., LAVIPHARM GROUP HOLDING S.A., Luye Pharma Group Ltd, Medherant Limited, Nitto Denko Corporation, Novartis AG, Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc., Nutriband Inc, Perrigo Company plc, ProSolus, Inc., Purdue Pharma L.P., Sparsha Pharma International Pvt Ltd, Tapemark by LTS Lohmann Therapie-Systeme AG, Teikoku Seiyaku Co., Ltd., Tesa SE by Beiersdorf AG, Teva Pharmaceutical Industries Ltd., UCB S.A., Viatris Inc., and Zydus Group.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Transdermal Patches Market, by Product
7. Transdermal Patches Market, by Type
8. Transdermal Patches Market, by Technology
9. Transdermal Patches Market, by Application
10. Transdermal Patches Market, by Distribution Channel
11. Transdermal Patches Market, by End Users
12. Americas Transdermal Patches Market
13. Asia-Pacific Transdermal Patches Market
14. Europe, Middle East & Africa Transdermal Patches Market
15. Competitive Landscape
16. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Transdermal Patches Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Transdermal Patches Market?
3. What is the competitive strategic window for opportunities in the Transdermal Patches Market?
4. What are the technology trends and regulatory frameworks in the Transdermal Patches Market?
5. What is the market share of the leading vendors in the Transdermal Patches Market?
6. What modes and strategic moves are considered suitable for entering the Transdermal Patches Market?

Read More @ https://www.360iresearch.com/library/intelligence/transdermal-patches?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.